← Leaderboards
Arvind Ravi
Dana-Farber Cancer Inst
$341,280
Attributed
$341,280
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $170.6K · FY2020–21$200K$150K$100K$50K$0
'20
'21
Funding mix
By agency
NIH$341,280 · 1
By mechanism
K99$341,280 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Tracy T Batchelor$27,819,477
- Sapna Syngal$13,605,208
- Nathanael Schiander Gray$36,761,550
- Rameen Beroukhim$9,639,646
- Dipanjan Chowdhury$12,356,287
Others in their field
Other Emerging Leaders on “Advanced Malignant Neoplasm”
- Leonard Freedman · Leidos Biomedical Research, Inc.$354,493,986
- Leonard Freedmand · Leidos Biomedical Research, Inc.$79,963,641
- Lynn Briscoe · Leidos Biomedical Research, Inc.$47,097,978
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,689,457
- Tareq Al Baghdadi · Saint Joseph Mercy Health System$19,225,531
Research focus
Advanced Malignant NeoplasmAppointmentAlkylating AgentsBar CodesCancer BiologyCancer Cell LineCancer ControlAtac-SeqCareerCareer DevelopmentCell LineCellsChek2 GeneCisplatinClinically RelevantCloningClustered Regularly Interspaced Short Palindromic RepeatsCancer TherapyCombined Modality TherapyDesignDisorder ControlDna Repair GeneDoctor Of PhilosophyDose